We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SLGN:NYSESilgan Holdings Inc. Analysis

Data as of 2026-05-28 - not real-time

$37.99

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Silgan Holdings (SLGN) is trading at $37.99, which sits below its 20‑day SMA of $38.87 and the 50‑day SMA of $39.51, indicating short‑term weakness. The bearish MACD (line below signal) and a neutral‑to‑slightly‑low RSI of 42 reinforce a down‑trend, while volume has been decreasing, suggesting waning buying pressure. The stock is hovering just above the identified support at $36.5 and below the near‑term resistance of $42.11, leaving limited upside on the chart in the next few weeks. On the valuation side, the trailing P/E of 14.2 and forward P/E of 9.3 are modest, and the price‑to‑book of 1.73 is in line with industry norms. Analysts project a mean target price of $53.2, implying roughly a 40% upside from current levels, and the market sentiment is in “Extreme Greed” per the Fear & Greed Index. The company delivers a 2.21% dividend with a comfortable payout ratio of 30%, supported by $276 M of free cash flow.
However, the balance sheet is leveraged, with a debt‑to‑equity of over 200% and total debt exceeding cash by more than $4 B, which adds financial risk. Operating margins are modest (operating margin 8.7%, profit margin 4.3%) and gross margin sits at only 17.4%, highlighting limited pricing power. Revenue is growing at 6.5% YoY, driven by steady demand for rigid packaging across consumer goods, which provides a stable earnings base. The beta of 0.67 indicates lower systematic risk relative to the market, while 30‑day volatility of nearly 30% points to higher price swings. Given the dividend yield, attractive forward earnings multiple, and analyst upside, the stock appears undervalued despite short‑term technical weakness. Overall, investors may consider holding for dividend income while positioning for a potential rebound as earnings improve and the price approaches its target.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish technical indicators (price below SMAs, MACD negative)
  • Decreasing volume and proximity to support level
  • Attractive dividend yield of 2.21% with low payout ratio

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst consensus target price ~ $53 implying ~40% upside
  • Forward P/E of 9.3 suggests strong earnings growth
  • Sustainable dividend and positive free cash flow

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Essential consumer packaging demand provides stable revenue base
  • Dividend yield and payout ratio support total return
  • Improving earnings outlook despite high leverage, manageable with cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth6.50%
Profit Margin4.31%
P/E Ratio14.2
ROE12.87%
ROA4.52%
Debt/Equity200.83
P/B Ratio1.7
Op. Cash Flow$613.7M
Free Cash Flow$276.6M

Technical Analysis

TrendBearish
RSI42.4
Support$36.50
Resistance$42.11
MA 20$38.87
MA 50$39.51
MA 200$42.15
MACDBearish
VolumeDecreasing
Fear & Greed Index92.34

Valuation

Fair Value$5.43
Target Price$53.17
Upside/Downside39.95%
GradeUndervalued
TypeBlend
Dividend Yield2.21%

Risk Assessment

Beta0.67
Volatility29.61%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.